Skip to main content
FinSpry Logo
FinSpry
REGN logo
REGN
(NASDAQ)
Regeneron Pharmaceuticals, Inc.
$807.65-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Regeneron Pharmaceuticals, Inc. (REGN) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Regeneron Pharmaceuticals, Inc. stock.

Analyst Consensus Rating

Investment consensus from 18 professional research analysts

Consensus Rating

Buy
Based on 18 unique analysts
High Confidence11.0:1 Buy/Sell

Average Price Target

$737.53
↓ 8.68% Downside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest REGN Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Tazeen Ahmad
BofA Securities
BuyReiterates
$860.00 → $856.00
Evan Seigerman
BMO Capital
BuyMaintains
$730.00
Biren Amin
Piper Sandler
BuyReiterates
$854.00
Mohit Bansal
Wells Fargo
HoldReiterates
$700.00
Terence Flynn
Morgan Stanley
HoldMaintains
$788.00 → $730.00
Gregory Renza
Truist
BuyMaintains
$778.00 → $769.00
Brian Abrahams
RBC Capital
HoldMaintains
$707.00 → $696.00
Carter Gould
Cantor Fitzgerald
BuyMaintains
$785.00 → $750.00
Rajesh Kumar
HSBC
BuyMaintains
$990.00 → $800.00
Ahan Chakraborty
Zacks Equity Research
SellInitiates Coverage
-
Louise Chen
Scotiabank
HoldMaintains
$770.00
Geoff Meacham
Citi
HoldMaintains
$700.00
Google Biotechnology
TipRanks - Google
BuyReiterates
$710.00 → $704.00
PerPlexity Biotechnology
TipRanks - PerPlexity
BuyReiterates
$676.00 → $728.00
Anthropic Biotechnology
TipRanks - Anthropic
HoldReiterates
$670.00 → $661.00
DeepSeek Biotechnology
TipRanks - DeepSeek
BuyReiterates
$702.00 → $695.00
xAi Biotechnology
TipRanks - xAI
BuyDowngrades
$667.00 → $707.00
OpenAI Biotechnology
TipRanks - OpenAI
BuyReiterates
$689.00 → $688.00

Frequently Asked Questions

What is the analyst consensus rating for REGN?

The analyst consensus rating for REGN is "Buy" based on 18 analyst recommendations.

What is the average price target for REGN?

The average 12-month price target for REGN is $737.53, representing a downside of 8.7% from the current price of $807.65.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.